Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
100.69
+7.36 (7.89%)
At close: Mar 27, 2026

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26,65324,53816,49414,01410,00814,112
Market Cap Growth
22.69%48.77%17.70%40.02%-29.08%-9.11%
Enterprise Value
25,75523,57815,21312,6589,44313,028
Last Close Price
100.6992.7062.3152.9441.7058.80
Forward PE
114.6435.5135.5135.5135.51-
PS Ratio
32.8930.2830.9536.2633.1174.13
PB Ratio
24.6722.7113.178.5212.7111.26
P/TBV Ratio
25.3923.3713.708.9614.9813.07
P/OCF Ratio
--431.73---
EV/Sales Ratio
31.7829.0928.5432.7631.2468.44
Debt / Equity Ratio
1.051.050.830.540.700.18
Net Debt / Equity Ratio
-0.83-0.83-0.92-0.83-0.63-0.78
Net Debt / EBITDA Ratio
5.875.876.633.821.032.11
Net Debt / FCF Ratio
4.274.2720.094.601.091.86
Asset Turnover
0.270.270.180.170.180.10
Inventory Turnover
0.440.440.260.300.370.19
Quick Ratio
1.541.541.712.081.573.35
Current Ratio
1.711.711.882.221.773.69
Return on Equity (ROE)
-14.16%-14.16%-10.37%-24.27%-47.59%-31.38%
Return on Assets (ROA)
-4.09%-4.09%-4.60%-10.91%-19.70%-17.02%
Return on Capital Employed (ROCE)
-12.70%-12.70%-13.30%-22.70%-57.30%-37.10%
Earnings Yield
-0.61%-0.66%-0.84%-1.99%-4.57%-3.20%
FCF Yield
-0.79%-0.86%-0.35%-2.11%-4.59%-3.72%
Buyback Yield / Dilution
0.85%0.85%-3.71%-6.74%0.19%-2.20%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.